Insights
How Emerging Biomarkers in Non-Small Cell Lung Cancer are Driving New and More Innovative Targeted Treatments
Lung cancer is one of the most common tumors and about 228,000 new cases will be diagnosed in the United...
Prognos Intern Spotlight: Olivia Sborlini
I am from King of Prussia, Pennsylvania but during the summers I spend a lot of time in Lewes, Delaware...
Lab Testing Trends Year-to-Date Through July 17
For the week ending July 17, national lab testing volumes increased 21% compared to the previous week. See the whole story on how testing trends…
Lab Testing Trends Year-to-Date Through July 10
For the week ending July 10, national lab testing volumes dropped about 7% compared to the previous week. Learn why this may have happened.
Lab Testing Trends Year-to-Date Through July 3
Despite a holiday week, market trends in lab testing volumes remain at a high point. See the latest trends.
Lab Testing Trends Year-to-Date Through June 26
Market trends in lab testing volumes are continuing to grow week-over-week. See the latest trends.
Lab Testing Trends Year-to-Date Through June 19
Market trends in lab testing volumes are not only showing signs of recovery but overall growth. See the latest trends.
Lab Testing Trends Year-to-Date Through June 12
As the market trend has stabilized, see the latest trends and what we're seeing as signs of recovery in lab testing volumes.
Lab Testing Trends Year-to-Date Through June 5
Prognos is analyzing lab testing trends in 2020 and more specifically, looking at the impact of COVID-19. See the latest trends.
How Prognos is Using COVID-19 Data
On May 20th, 2020, Jaclyn Fink presented to Women In Data's NYC Chapter on how clinical lab data is being analyzed.